Subscribe To
Ardelyx (ardx) up on fda nod to xphozah for hyperphosphatemia
Ardelyx (ARDX) gets FDA approval for Xphozah to reduce serum phosphorus in adult patients with kidney d...
October 19, 2023, 12:02 pm
Why ardelyx stock popped today
Late yesterday, Ardelyx announced that the FDA has approved its first-in-class chronic kidney disease drug Xphozah. The drug adds an important new tre...
October 18, 2023, 4:31 pm
phosphorus appoints martin leroy as chief financial officer
LeRoy is a top industry veteran who was pivotal in SailPoint’s 5x value increase, culminating in acquisition NASHVILLE, Tenn., Jan. 25, 2023 (GLOBE ...
January 25, 2023, 12:00 pm
Perimeter solutions: a moat full of alligators in the aerial retard market
Perimeter Solutions operates as the only current player in the North American aerial fire retardant market, estimated conservatively at $300 million p...
August 7, 2022, 12:45 pm